|
Market Closed -
NYSE
01:30:00 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.360 USD | -9.92% |
|
-3.28% | +31.11% |
| 12/08 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 12/08 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.42x | - | -0.04x | - | - | - | - | 19Cr | |
| 34.32x | 22.02x | 0.64x | 12.47x | 25.45x | 26.72x | 0.57% | 1,07800Cr | |
| 29.15x | - | -1.58x | - | - | - | 2.05% | 63TCr | |
| 32.02x | -434.29x | 0.14x | 7.45x | 15.48x | 16.1x | 2.73% | 44TCr | |
| 20.19x | 7.25x | 1.7x | 4.79x | 11.87x | 13.16x | 2.76% | 36TCr | |
| 21.62x | 6.09x | -9.41x | 5.6x | 13.97x | 14.81x | 2.87% | 29TCr | |
| 20.24x | 4.55x | 1.04x | 4.18x | 11.87x | 12.56x | 2.1% | 25TCr | |
| 26.43x | 20.4x | 2.38x | 6.88x | 12.21x | 15.79x | 2.41% | 23TCr | |
| 13.48x | 5.65x | -3.42x | 4.84x | 10.07x | 11.82x | 3.78% | 20TCr | |
| -42.9x | 8.53x | 0.29x | 6.13x | 34.58x | 59.31x | 2.39% | 17TCr | |
| 16.79x | 1.74x | 0.97x | 3.22x | 8.21x | 9.37x | 6.42% | 15TCr | |
| 30.42x | 5.71x | 2.81x | 8.85x | 20.01x | 20.84x | -.--% | 13TCr | |
| 11.52x | 5.43x | 0.19x | 3.23x | 8.45x | 9.07x | 3.91% | 13TCr | |
| 12.15x | 1.24x | -7.18x | 2.16x | 6.99x | 7.77x | 5.57% | 11TCr | |
| 13.77x | 4.47x | -3.09x | 2.75x | 8.14x | 9.07x | 3.75% | 10TCr | |
| 23.27x | 5.25x | 1.38x | 7.84x | 14.88x | 15.58x | 1.9% | 7.41TCr | |
| 44.65x | 1.19x | 21.84x | 2.74x | 9.67x | 28.85x | 3.68% | 5.57TCr | |
| 20.28x | 1.68x | -0.12x | 1.67x | 7.9x | 13.7x | 0.33% | 5.45TCr | |
| 38.56x | 5.13x | 2.12x | 8.72x | 29.14x | 30.49x | 0.49% | 5.25TCr | |
| 18.62x | 1.86x | 4.74x | 3.37x | 12.58x | 14.02x | 2.26% | 4.26TCr | |
| Average | 19.85x | -18.12x | 0.77x | 5.38x | 14.53x | 18.28x | 2.63% | 22.72TCr | |
| Weighted average by Cap. | 23.81x | -39.07x | -0.25x | 7.33x | 17.09x | 19.65x | 2.23% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
